Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$161,250
+$48,488 QoQ
Shares Held
56,979
+6.6% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NKTX ranks #289 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $161,250 | 56,979 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $112,762 | 53,442 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $203,533 | 110,019 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $915,960 | 442,493 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,232,911 | 742,718 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,489,232 | 809,366 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $947,304 | 380,444 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $818,566 | 181,099 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $679,702 | 115,009 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $436,420 | 40,372 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $806,156 | 122,145 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $155,371 | 111,778 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $181,368 | 82,817 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $449,233 | 126,545 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $305,093 | 50,934 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,943,178 | 147,658 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $796,672 | 64,665 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $862,386 | 75,781 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $910,131 | 59,292 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,175,639 | 42,274 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,506,700 | 47,545 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,857,994 | 56,474 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,150,348 | 18,714 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $208,856 | 6,948 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||